Study on Umbilical Cord-Matrix Stem Cells Transplantation for Treatment of Acute Traumatic Brain Injury in Rats

In MSCs group, GFP in the brain tissue and thearea around the vessels were found after the injection, while the expression levels of micro-vessel density (MVD), brain-derivedneurotrophic factor (BDNF) and glial fibrillary acidic protein (GFAP) were elevated.CONCLUSION: UC-MSCs transplantation for treatment of acute TBI could effectively reduce the injury and improve the vascularreconstruction.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:AIM: To evaluate the effect of umbilical cord derived mesenchymal stem cells (UC-MSCs) transplantation on traumatic brain injury(TBI).MATERIAL and METHODS: UC-MSCs were isolated from human umbilical cord and TBI rat model was constructed. 30 male SDrats were randomly divided into 3 groups: control group, TBI group and MSCs transplantation group.

📊

Key Findings & Data:Rats in MSCs group receivedthe injection of a total of 1.5 × 106 MSCs (25 μl) via ventricle at operated ventricular coordinates (0 at bregma, 1.5 mm at lateral, 1.1mm at behind, 4.5 mm in depth).RESULTS: 80% confluence of cells was formed from tissue at day 10 and the amount of CD90, CD73, CD105 positive cellsincreased correspondingly.

💡

Conclusion & Impact:In MSCs group, GFP in the brain tissue and thearea around the vessels were found after the injection, while the expression levels of micro-vessel density (MVD), brain-derivedneurotrophic factor (BDNF) and glial fibrillary acidic protein (GFAP) were elevated.CONCLUSION: UC-MSCs transplantation for treatment of acute TBI could effectively reduce the injury and improve the vascularreconstruction.

🔬Design:Modeling & Simulation

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

AIM: To evaluate the effect of umbilical cord derived mesenchymal stem cells (UC-MSCs) transplantation on traumatic brain injury(TBI).MATERIAL and METHODS: UC-MSCs were isolated from human umbilical cord and TBI rat model was constructed. 30 male SDrats were randomly divided into 3 groups: control group, TBI group and MSCs transplantation group. Rats in MSCs group receivedthe injection of a total of 1.5 × 106 MSCs (25 μl) via ventricle at operated ventricular coordinates (0 at bregma, 1.5 mm at lateral, 1.1mm at behind, 4.5 mm in depth).RESULTS: 80% confluence of cells was formed from tissue at day 10 and the amount of CD90, CD73, CD105 positive cellsincreased correspondingly. In TBI model, clear hyperemia, edema and obvious infiltration of inflammatory cells in brain tissue werefound. However, the manifestations were alleviated after the treatment of MSCs. In MSCs group, GFP in the brain tissue and thearea around the vessels were found after the injection, while the expression levels of micro-vessel density (MVD), brain-derivedneurotrophic factor (BDNF) and glial fibrillary acidic protein (GFAP) were elevated.CONCLUSION: UC-MSCs transplantation for treatment of acute TBI could effectively reduce the injury and improve the vascularreconstruction.

🔖

Cite This Article

WANG, L., DONG, H., HU, Q., PENG, D., SHA, H., SHANG, C., WANG, Y., Yang, X., HUANG, P., YE, H., HUI, Y., WANG, X., SUN, W., WU, H., ZHANG, S. (2022). Study on Umbilical Cord-Matrix Stem Cells Transplantation for Treatment of Acute Traumatic Brain Injury in Rats. Turkish Neurosurgery, Cilt: 29 - Sayı: 5, 750–758. https://ajindex.com/articles/616906

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Ankrum J, Karp JM: Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med 16:203-209, 2010 2. Chan J, O’Donoghue K, de la Fuente J, Roberts IA, Kumar S, Morgan JE, Fisk NM: Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23:93-102, 2005 3. Choi M, Ban T, Rhim T: Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell. Mol Cells 37:133-139, 2014 4. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A: Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372, 2006 5. Ding DC, Chang YH, Shyu WC, Lin SZ: Human umbilical cord mesenchymal stem cells: A new era for stem cell therapy. Cell Transplant 24:339-347, 2015 6. Dong H, Li G, Shang C, Yin H, Luo Y, Meng H, Li X, Wang Y, Lin L, Zhao M: Umbilical cord mesenchymal stem cell (UCMSC) transplantations for cerebral palsy. Am J Transl Res 10:901-906, 2018 7. Dong HJ, Li G, Meng HP, Shang CZ, Luo Y, Wen G, Zhao ML: How can Mesenchymal Stem Cells (MSCs) penetrate the blood brain barrier (BBB)? Turk Neurosurg 2018 (Epub ahead of print) 8. Dong HJ, Peng D, Zhao M, Wang L, Luo Y: Meeting prometheus: The mechanism of MSC-based therapies; cell replacement or “pretended bystander effects”? Turk Neurosurg 2018 (Epub ahead of print) 9. Dong HJ, Shang C, Li G, Luo YC, Yang Y, Lin L, Zhao ML: Differential protein expression in an acute disseminated myelitis patient after treatment with umbilical cord mesenchymal stem cells. Int J Clin Exp Med 10:7213-7219, 2017 10. El Omar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V: Umbilical cord mesenchymal stem cells: The new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev 20:523-544, 2014 11. Galindo LT, Filippo TR, Semedo P, Ariza CB, Moreira CM, Camara NO, Porcionatto MA: Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol Res Int 2011:1-9, 2011 12. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F: Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105:2821-2827, 2005 13. Gokcinar-Yagci B, Uckan-Cetinkaya D, Celebi-Saltik B: Pericytes: Properties, functions and applications in tissue engineering. Stem Cell Rev 11:549-559, 2015 14. Gong W, Han Z, Zhao H, Wang Y, Wang J, Zhong J, Wang B, Wang S, Wang Y, Sun L, Han Z: Banki